Spanish flu, polio epidemics, and the ongoing COVID-19 pandemic are the most profound examples of severe widespread diseases caused by RNA viruses. The coronavirus pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) demands affordable and reliable assays for testing antivirals. To test inhibitors of viral proteases, we have developed an inexpensive high-throughput assay based on fluorescent energy transfer (FRET). We assayed an array of inhibitors for papain-like protease from SARS-CoV-2 and validated it on protease from the tick-borne encephalitis virus to emphasize its versatility. The reaction progress is monitored as loss of FRET signal of the substrate. This robust and reproducible assay can be used for testing the inhibitors in 96- or 384-well plates.

Institute of Organic Chemistry and Biochemistry Czech Academy of Sciences Flemingovo namesti 2 166 10 Prague 6 Czech Republic

Zobrazit více v PubMed

Woolhouse M.E.J., Brierley L. Epidemiological characteristics of human-infective RNA viruses. Sci. Data. 2018;5:180017. doi: 10.1038/sdata.2018.17. PubMed DOI PMC

Wolf Y.I., Kazlauskas D., Iranzo J., Lucia-Sanz A., Kuhn J.H., Krupovic M., Dolja V.V., Koonin E.V. Origins and evolution of the global RNA virome. MBio. 2018;9:e02329-18. doi: 10.1128/mBio.02329-18. PubMed DOI PMC

Domingo E., Holland J.J. RNA virus mutations and fitness for survival. Annu. Rev. Microbiol. 1997;51:151–178. doi: 10.1146/annurev.micro.51.1.151. PubMed DOI

Bentley K., Evans D.J. Mechanisms and consequences of positive-strand RNA virus recombination. J. Gen. Virol. 2018;99:1345–1356. doi: 10.1099/jgv.0.001142. PubMed DOI

Rosenberg R. Detecting the emergence of novel, zoonotic viruses pathogenic to humans. Cell Mol. Life Sci. 2015;72:1115–1125. doi: 10.1007/s00018-014-1785-y. PubMed DOI PMC

Holmes E.C. The evolutionary genetics of emerging viruses. Annu. Rev. Ecol. Evol. Syst. 2009;40:353–372. doi: 10.1146/annurev.ecolsys.110308.120248. DOI

De Clercq E. Strategies in the design of antiviral drugs. Nat. Rev. Drug Discov. 2002;1:13–25. doi: 10.1038/nrd703. PubMed DOI

Dzimianski J.V., Scholte F.E.M., Bergeron E., Pegan S.D. ISG15: It’s complicated. J. Mol. Biol. 2019;431:4203–4216. doi: 10.1016/j.jmb.2019.03.013. PubMed DOI PMC

Perng Y.C., Lenschow D.J. ISG15 in antiviral immunity and beyond. Nat. Rev. Microbiol. 2018;16:423–439. doi: 10.1038/s41579-018-0020-5. PubMed DOI PMC

Devaraj S.G., Wang N., Chen Z., Chen Z., Tseng M., Barretto N., Lin R., Peters C.J., Tseng C.T., Baker S.C., et al. Regulation of IRF-3-dependent innate immunity by the papain-like protease domain of the severe acute respiratory syndrome coronavirus. J. Biol. Chem. 2007;282:32208–32221. doi: 10.1074/jbc.M704870200. PubMed DOI PMC

Bailey-Elkin B.A., Knaap R.C., Johnson G.G., Dalebout T.J., Ninaber D.K., van Kasteren P.B., Bredenbeek P.J., Snijder E.J., Kikkert M., Mark B.L. Crystal structure of the Middle East respiratory syndrome coronavirus (MERS-CoV) papain-like protease bound to ubiquitin facilitates targeted disruption of deubiquitinating activity to demonstrate its role in innate immune suppression. J. Biol. Chem. 2014;289:34667–34682. doi: 10.1074/jbc.M114.609644. PubMed DOI PMC

Ratia K., Pegan S., Takayama J., Sleeman K., Coughlin M., Baliji S., Chaudhuri R., Fu W., Prabhakar B.S., Johnson M.E., et al. A noncovalent class of papain-like protease/deubiquitinase inhibitors blocks SARS virus replication. Proc. Natl. Acad. Sci. USA. 2008;105:16119–16124. doi: 10.1073/pnas.0805240105. PubMed DOI PMC

Ruzek D., Zupanc T.A., Borde J., Chrdle A., Eyer L., Karganova G., Kholodilov I., Knap N., Kozlovskaya L., Matveev A., et al. Tick-borne encephalitis in Europe and Russia: Review of pathogenesis, clinical features, therapy, and vaccines. Antivir. Res. 2019;164:23–51. doi: 10.1016/j.antiviral.2019.01.014. PubMed DOI

Piesman J., Eisen L. Prevention of tick-borne diseases. Annu. Rev. Entomol. 2008;53:323–343. doi: 10.1146/annurev.ento.53.103106.093429. PubMed DOI

Pfeffer M., Dobler G. Emergence of zoonotic arboviruses by animal trade and migration. Parasit. Vectors. 2010;3:35. doi: 10.1186/1756-3305-3-35. PubMed DOI PMC

Dubankova A., Boura E. Structure of the yellow fever NS5 protein reveals conserved drug targets shared among flaviviruses. Antivir. Res. 2019;169:104536. doi: 10.1016/j.antiviral.2019.104536. PubMed DOI

Erbel P., Schiering N., D’Arcy A., Renatus M., Kroemer M., Lim S.P., Yin Z., Keller T.H., Vasudevan S.G., Hommel U. Structural basis for the activation of flaviviral NS3 proteases from dengue and West Nile virus. Nat. Struct. Mol. Biol. 2006;13:372–373. doi: 10.1038/nsmb1073. PubMed DOI

Phoo W.W., Li Y., Zhang Z., Lee M.Y., Loh Y.R., Tan Y.B., Ng E.Y., Lescar J., Kang C., Luo D. Structure of the NS2B-NS3 protease from Zika virus after self- cleavage. Nat. Commun. 2016;7:13410. doi: 10.1038/ncomms13410. PubMed DOI PMC

Hercik K., Brynda J., Nencka R., Boura E. Structural basis of Zika virus methyltransferase inhibition by sinefungin. Arch. Virol. 2017;162:2091–2096. doi: 10.1007/s00705-017-3345-x. PubMed DOI

Hercik K., Kozak J., Sala M., Dejmek M., Hrebabecky H., Zbornikova E., Smola M., Ruzek D., Nencka R., Boura E. Adenosine triphosphate analogs can efficiently inhibit the Zika virus RNA-dependent RNA polymerase. Antivir. Res. 2017;137:131–133. doi: 10.1016/j.antiviral.2016.11.020. PubMed DOI

Konkolova E., Dejmek M., Hrebabecky H., Sala M., Boserle J., Nencka R., Boura E. Remdesivir triphosphate can efficiently inhibit the RNA-dependent RNA polymerase from various flaviviruses. Antivir. Res. 2020;182:104899. doi: 10.1016/j.antiviral.2020.104899. PubMed DOI PMC

da Fonseca N.J., Jr., Afonso M.Q.L., Pedersolli N.G., de Oliveira L.C., Andrade D.S., Bleicher L. Sequence, structure and function relationships in flaviviruses as assessed by evolutive aspects of its conserved non-structural protein domains. Biochem. Biophys. Res. Commun. 2017;492:565–571. doi: 10.1016/j.bbrc.2017.01.041. PubMed DOI

Chambers T.J., Weir R.C., Grakoui A., McCourt D.W., Bazan J.F., Fletterick R.J., Rice C.M. Evidence that the N-terminal domain of nonstructural protein NS3 from yellow fever virus is a serine protease responsible for site-specific cleavages in the viral polyprotein. Proc. Natl. Acad. Sci. USA. 1990;87:8898–8902. doi: 10.1073/pnas.87.22.8898. PubMed DOI PMC

Carnero A. High throughput screening in drug discovery. Clin. Transl. Oncol. 2006;8:482–490. doi: 10.1007/s12094-006-0048-2. PubMed DOI

Lakowicz J.R. Principles of Fluorescence Spectroscopy. 3rd ed. Volume 26. Springer; New York, NY, USA: 2006. p. 945.

Albertazzi L., Arosio D., Marchetti L., Ricci F., Beltram F. Quantitative FRET analysis with the E0GFP-mCherry fluorescent protein pair. Photochem. Photobiol. 2009;85:287–297. doi: 10.1111/j.1751-1097.2008.00435.x. PubMed DOI

Jin S., Ellis E., Veetil J.V., Yao H., Ye K. Visualization of human immunodeficiency virus protease inhibition using a novel Förster resonance energy transfer molecular probe. Biotechnol. Prog. 2011;27:1107–1114. doi: 10.1002/btpr.628. PubMed DOI PMC

Neefjes J., Dantuma N.P. Fluorescent probes for proteolysis: Tools for drug discovery. Nat. Rev. Drug Discov. 2004;3:58–69. doi: 10.1038/nrd1282. PubMed DOI PMC

Shannon A.E., Pedroso M.M., Chappell K.J., Watterson D., Liebscher S., Kok W.M., Fairlie D.P., Schenk G., Young P.R. Product release is rate-limiting for catalytic processing by the Dengue virus protease. Sci. Rep. 2016;6:37539. doi: 10.1038/srep37539. PubMed DOI PMC

Shin D., Mukherjee R., Grewe D., Bojkova D., Baek K., Bhattacharya A., Schulz L., Widera M., Mehdipour A.R., Tascher G., et al. Papain-like protease regulates SARS-CoV- 2 viral spread and innate immunity. Nature. 2020;587:657–662. doi: 10.1038/s41586-020-2601-5. PubMed DOI PMC

Voss S., Nitsche C. Inhibitors of the Zika virus protease NS2B-NS3. Bioorg. Med. Chem. Lett. 2020;30:126965. doi: 10.1016/j.bmcl.2020.126965. PubMed DOI

Billinger E., Viljanen J., Lind S.B., Johansson G. Inhibition properties of free and conjugated leupeptin analogues. FEBS Open Bio. 2020;10:2605–2615. doi: 10.1002/2211-5463.12994. PubMed DOI PMC

Ghosh A.K., Takayama J., Aubin Y., Ratia K., Chaudhuri R., Baez Y., Sleeman K., Coughlin M., Nichols D.B., Mulhearn D.C., et al. Structure-based design, synthesis, and biological evaluation of a series of novel and reversible inhibitors for the severe acute respiratory syndrome- coronavirus papain-like protease. J. Med. Chem. 2009;52:5228–5240. doi: 10.1021/jm900611t. PubMed DOI PMC

Galkin A., Kulakova L., Lim K., Chen C.Z., Zheng W., Turko I.V., Herzberg O. Structural basis for inactivation of Giardia lamblia carbamate Kinase by disulfiram. J. Biol. Chem. 2014;289:10502–10509. doi: 10.1074/jbc.M114.553123. PubMed DOI PMC

Lin M.H., Moses D.C., Hsieh C.H., Cheng S.C., Chen Y.H., Sun C.Y., Chou C.Y. Disulfiram can inhibit MERS and SARS coronavirus papain-like proteases via different modes. Antivir. Res. 2018;150:155–163. doi: 10.1016/j.antiviral.2017.12.015. PubMed DOI PMC

Shiryaev S.A., Ratnikov B.I., Chekanov A.V., Sikora S., Rozanov D.V., Godzik A., Wang J., Smith J.W., Huang Z., Lindberg I., et al. Cleavage targets and the D-arginine-based inhibitors of the West Nile virus NS3 processing proteinase. Biochem. J. 2006;393 Pt 2:503–511. doi: 10.1042/BJ20051374. PubMed DOI PMC

Leung D., Schroder K., White H., Fang N.X., Stoermer M.J., Abbenante G., Martin J.L., Young P.R., Fairlie D.P. Activity of recombinant dengue 2 virus NS3 protease in the presence of a truncated NS2B co-factor, small peptide substrates, and inhibitors. J. Biol. Chem. 2001;276:45762–45771. doi: 10.1074/jbc.M107360200. PubMed DOI

Liu Y., Song Y., Madahar V., Liao J. Quantitative Forster resonance energy transfer analysis for kinetic determinations of SUMO-specific protease. Anal. Biochem. 2012;422:14–21. doi: 10.1016/j.ab.2011.12.019. PubMed DOI

Nakata H., Ohtsuki T., Sisido M. A protease inhibitor discovery method using fluorescence correlation spectroscopy with position-specific labeled protein substrates. Anal. Biochem. 2009;390:121–125. doi: 10.1016/j.ab.2009.03.049. PubMed DOI

Degorce F., Card A., Soh S., Trinquet E., Knapik G.P., Xie B. HTRF: A technology tailored for drug discovery—a review of theoretical aspects and recent applications. Curr. Chem. Genom. 2009;3:22–32. doi: 10.2174/1875397300903010022. PubMed DOI PMC

Gibson D.G., Young L., Chuang R.Y., Venter J.C., Hutchison C.A., 3rd, Smith H.O. Enzymatic assembly of DNA molecules up to several hundred kilobases. Nat. Methods. 2009;6:343–345. doi: 10.1038/nmeth.1318. PubMed DOI

Zhang J.H., Chung T.D., Oldenburg K.R. A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J. Biomol. Screen. 1999;4:67–73. doi: 10.1177/108705719900400206. PubMed DOI

Model of abasic site DNA cross-link repair; from the architecture of NEIL3 DNA binding domains to the X-structure model

A Helquat-like Compound as a Potent Inhibitor of Flaviviral and Coronaviral Polymerases

Coronaviral RNA-methyltransferases: function, structure and inhibition

Precursors of Viral Proteases as Distinct Drug Targets